Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Vet Res ; 72(8): 1052-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21801062

RESUMEN

OBJECTIVE: To evaluate and compare circulating concentrations of islet amyloid polypeptide (IAPP), insulin, and glucose in nondiabetic cats classified by body condition score (BCS) and in cats with naturally occurring diabetes mellitus. ANIMALS: 109 (82 nondiabetic, 21 nonketoacidotic diabetic, and 6 ketoacidotic diabetic) cats. PROCEDURES: Cats were examined and BCSs were assessed on a scale of 1 to 9. After food was withheld for 12 hours, blood was collected and plasma concentrations of IAPP and serum concentrations of insulin and glucose were measured. Differences in these values were evaluated among nondiabetic cats grouped according to BCS and in diabetic cats grouped as ketoacidotic or nonketoacidotic on the basis of clinicopathologic findings. Correlations were determined among variables. RESULTS: In nondiabetic cats, BCS was significantly and positively correlated with circulating IAPP and insulin concentrations. Mean plasma IAPP concentrations were significantly different between cats with BCSs of 5 and 7, and mean serum insulin concentrations were significantly different between cats with BCSs of 5 and 8. Serum glucose concentrations were not significantly different among nondiabetic cats. Mean IAPP concentrations were similar between nonketoacidotic diabetic cats and nondiabetic cats with BCSs of 8 or 9. Mean IAPP concentrations were significantly reduced in ketoacidotic diabetic cats, compared with those of nondiabetic cats with BCSs of 6 through 8 and of nonketoacidotic diabetic cats. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that increased BCS (a measure of obesity) is associated with increased circulating concentrations of IAPP and insulin in nondiabetic cats.


Asunto(s)
Enfermedades de los Gatos/fisiopatología , Diabetes Mellitus/veterinaria , Animales , Glucemia/análisis , Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/metabolismo , Gatos , Diabetes Mellitus/sangre , Diabetes Mellitus/metabolismo , Diabetes Mellitus/fisiopatología , Cetoacidosis Diabética/sangre , Cetoacidosis Diabética/metabolismo , Cetoacidosis Diabética/fisiopatología , Cetoacidosis Diabética/veterinaria , Femenino , Insulina/sangre , Insulina/metabolismo , Polipéptido Amiloide de los Islotes Pancreáticos/biosíntesis , Polipéptido Amiloide de los Islotes Pancreáticos/sangre , Modelos Lineales , Masculino , Estadísticas no Paramétricas
2.
J Am Anim Hosp Assoc ; 46(2): 127-31, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20194369

RESUMEN

Two dogs, 4 and 7 years of age, were presented for evaluation and treatment of excessive sneezing. Physical examinations in both cases were within acceptable limits except for the presence of a single mass in the left nasal passage in the first case and left-sided nasal discharge in the second case. Rhinoscopy was used to visualize the nasal masses, and in both cases a single mass was surgically removed. Impression smears and histopathology submitted from each mass revealed lymphoplasmacytic and neutrophilic inflammation with spores typical of Rhinosporidium seeberi. These are the first reported cases of nasal rhinosporidiosis in two dogs native to the Upper Mississippi River Valley area with no travel history outside the region.


Asunto(s)
Enfermedades de los Perros/cirugía , Cavidad Nasal/parasitología , Enfermedades Nasales/veterinaria , Rinosporidiosis/veterinaria , Rhinosporidium/aislamiento & purificación , Animales , Enfermedades de los Perros/parasitología , Perros , Masculino , Enfermedades Nasales/cirugía , Rinosporidiosis/cirugía , Resultado del Tratamiento
3.
J Am Anim Hosp Assoc ; 45(3): 147-50, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19411652

RESUMEN

An 11-year-old, spayed female miniature schnauzer with diabetes mellitus was presumptively diagnosed with Evans' syndrome (ES). Because of the potential adverse effects of immunosuppressive doses of glucocorticoids in a diabetic dog, a single infusion of human intravenous immunoglobulin and oral leflunomide were used as first-line immunomodulatory therapy, after informed owner consent was received. This treatment resulted in complete remission of the ES, and leflunomide was discontinued after 10 months of therapy. Over a 19-month follow-up, the dog did not relapse and has remained a well-regulated diabetic.


Asunto(s)
Anemia Hemolítica Autoinmune/veterinaria , Enfermedades de los Perros/tratamiento farmacológico , Inmunoglobulinas Intravenosas/administración & dosificación , Factores Inmunológicos/administración & dosificación , Isoxazoles/administración & dosificación , Púrpura Trombocitopénica Idiopática/veterinaria , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Animales , Diabetes Mellitus/veterinaria , Perros , Combinación de Medicamentos , Femenino , Inmunosupresores/administración & dosificación , Leflunamida , Púrpura Trombocitopénica Idiopática/complicaciones , Púrpura Trombocitopénica Idiopática/tratamiento farmacológico , Resultado del Tratamiento
4.
Am J Vet Res ; 69(2): 212-21, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18241018

RESUMEN

OBJECTIVE: To determine whether objectively applied ultrasonographic interpretive criteria are statistically useful in differentiating among 7 defined categories of diffuse liver disease in dogs and cats. SAMPLE POPULATION: Ultrasonographic images of 229 dogs and 104 cats. PROCEDURES: Liver parenchymal or related sonographic criteria established by the authors were retrospectively and independently applied by 3 radiologists who were not aware of patient status or patient laboratory data. Seven histologic or cytologic categories of diffuse (infiltrative but not nodular) liver diseases were jointly established by the authors and included normal liver; inflammation; round-cell neoplasia; non-round-cell infiltrative, prenodular (early) metastatic neoplasia; lipidosis; vacuolar hepatopathy; and other. Liver parenchymal sonographic criteria included parenchymal sound attenuation with increasing depth, comparative organ echogenicity (liver, spleen, and kidneys), diffuse or patchy hyperechoic or hypoechoic echotexture, uniform or coarse echotexture, portal venous clarity, and liver lobe geometry. Related extrahepatic criteria included gallbladder wall thickness, bile duct diameter, amount and character of gallbladder precipitate, nondependent shadowing in the gallbladder, hepatic vein diameter versus caudal vena cava diameter, peritoneal fluid, spleen echotexture (normal vs abnormal [characterized]), and kidney echotexture. Ultrasonographic criteria were statistically compared to the 7 categories of diffuse liver disease in search of clinically exploitable relationships. RESULTS: Statistical evaluation of the applied ultrasonographic criteria did not yield clinically acceptable accuracy for discrimination among the 7 categories of diffuse liver diseases (including normal liver) in either species. CONCLUSIONS AND CLINICAL RELEVANCE: Criterion-based ultrasonographic appearance was insufficient to discriminate among canine and feline diffuse infiltrative liver diseases.


Asunto(s)
Enfermedades de los Gatos/diagnóstico por imagen , Enfermedades de los Perros/diagnóstico por imagen , Hepatopatías/veterinaria , Hígado/diagnóstico por imagen , Animales , Enfermedades de los Gatos/patología , Gatos , Análisis Discriminante , Enfermedades de los Perros/patología , Perros , Hepatopatías/diagnóstico por imagen , Hepatopatías/patología , Especificidad de la Especie , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA